Proathlete Wealth Management’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.54K Buy
65
+53
+442% +$3.96K ﹤0.01% 513
2026
Q2
$868 Hold
12
– – ﹤0.01% 265
2026
Q1
$1.42K Sell
12
-95
-89% -$11.7K ﹤0.01% 236
2025
Q4
$13.5K Buy
107
+12
+13% +$1.56K ﹤0.01% 160
2025
Q3
$13.9K Buy
95
+1
+1% +$151 ﹤0.01% 148
2025
Q2
$14.8K Hold
94
– – ﹤0.01% 167
2025
Q1
$15.6K Buy
+94
New +$15.6K 0.01% 147

Other funds holding ZTS

Proathlete Wealth Management's ZTS Position: Q3 2026 in Review

Proathlete Wealth Management increased its Zoetis (ZTS) stake by 442% in Q3 2026, buying an estimated $3.96K and bringing the position to 65 shares worth $4.54K. The position accounts for ﹤0.01% of the portfolio, ranked #513.

Proathlete Wealth Management first reported a position in ZTS in Q1 2025 and has held it in 7 quarters since. The position peaked at $15.6K in Q1 2025. 1,000 funds tracked by Wall St. Rank hold ZTS as of Q3 2026.

  • Proathlete Wealth Management held 65 shares of Zoetis worth $4.54K as of Q3 2026.
  • Proathlete Wealth Management bought 53 Zoetis shares in Q3 2026, an estimated $3.96K.
  • Zoetis made up ﹤0.01% of Proathlete Wealth Management's portfolio in Q3 2026, its #513 holding.
  • Proathlete Wealth Management first reported a position in Zoetis in Q1 2025 and has held it in 7 quarters since.
  • Proathlete Wealth Management's Zoetis position peaked at $15.6K in Q1 2025.
  • 1,000 funds tracked by Wall St. Rank held Zoetis as of Q3 2026.

Based on Proathlete Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.